NCAM1 and ovarian carcinoma: Thus, E-Cadherin, P-Cadherin, Zeb1, HMGA2, Rab25, CD24, NCAM (CD56), Sox11 and Vimentin expression was assessed in 100 advanced-stage ovarian cancer patients undergoing platinum-based chemotherapy [237].